×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SYNCOM FORMULATIONS (INDIA) LT | 1225.67 | 157.29 | 1165.47 | 0.21 | 1,622 | 28.2 |
| JAGSONPAL PHARMACEUTICALS LTD. | 784.37 | 107.95 | 756.12 | 1.58 | 1586 | 37.2 |
| Bajaj Healthcare Limited | 1497.14 | 118.34 | 1488.36 | 3.75 | 1347 | 28.6 |
Syncom Formulations (India) Ltd., with Security Code 524470, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 61.4 | 59.4 | 62.4 | 63.3 | 73.3 | 86.8 | 101.5 | 127.0 | 148.5 | 116.5 |
| Expenses | 55.4 | 53.2 | 56.3 | 56.5 | 64.5 | 76.4 | 89.6 | 112.4 | 130.9 | 100.8 |
| Operating Profit | 5.9 | 6.2 | 6.1 | 6.8 | 8.8 | 10.5 | 11.9 | 14.6 | 17.5 | 15.8 |
| OPM % | 9.68% | 10.37% | 9.76% | 10.74% | 12.02% | 12.06% | 11.75% | 11.49% | 11.81% | 13.53% |
| Other Income | 6.8 | 1.9 | 4.0 | 4.3 | 2.9 | 1.3 | 4.2 | 3.8 | 6.9 | 6.1 |
| Interest | 1.3 | 1.1 | 1.1 | 1.1 | 1.2 | 0.4 | 0.2 | 0.2 | 0.1 | 0.2 |
| Depreciation | 1.2 | 1.1 | 0.9 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| Profit before tax | 10.3 | 5.8 | 8.1 | 8.6 | 9.2 | 10.1 | 14.7 | 16.9 | 23.1 | 20.2 |
| Tax % | -17.6% | -26.9% | -23.8% | -25.3% | -26.7% | -24.4% | -25.3% | -24.3% | -23.9% | 22.4% |
| Net Profit | 8.5 | 4.2 | 6.2 | 6.4 | 6.7 | 7.6 | 11.0 | 12.8 | 17.5 | 15.7 |
| EPS in Rs | 0.1 | 0.07 | 0.08 | 0.09 | 0.09 | 0.11 | 0.16 | 0.14 | 0 | 0.21 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 57.4 | 61.0 | 59.8 | 63.8 | 65.1 | 74.6 | 87.3 | 102.3 | 127.5 | 148.9 |
| Expenses | 51.5 | 55.0 | 53.4 | 57.4 | 57.8 | 65.1 | 76.8 | 90.2 | 112.8 | 131.1 |
| Operating Profit | 5.9 | 6.0 | 6.5 | 6.4 | 7.4 | 9.4 | 10.5 | 12.2 | 14.7 | 17.8 |
| OPM % | 10.29% | 9.78% | 10.8% | 10.04% | 11.3% | 12.64% | 11.98% | 11.89% | 11.55% | 11.94% |
| Other Income | 2.0 | 6.8 | 1.9 | 4.0 | 4.5 | 3.1 | 1.3 | 4.1 | 4.0 | 7.0 |
| Interest | 0.7 | 1.3 | 1.1 | 1.1 | 1.1 | 1.2 | 0.4 | 0.2 | 0.2 | 0.1 |
| Depreciation | 1.2 | 1.2 | 1.1 | 0.9 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| Profit before tax | 6.0 | 10.3 | 6.1 | 8.4 | 9.4 | 10.0 | 10.1 | 14.9 | 17.3 | 23.3 |
| Tax % | -30.5% | -17.6% | -28.1% | -22.9% | -25.2% | 26.2% | 24.5% | -25.2% | 24.7% | -24% |
| Net Profit | 4.1 | 8.5 | 4.4 | 6.5 | 7.0 | 7.4 | 7.6 | 11.1 | 13.0 | 17.7 |
| EPS in Rs | 0.06 | 0.1 | 0.07 | 0.08 | 0.09 | 0.1 | 0.11 | 0.16 | 0.14 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 18% |
| 3 Years: | 29% |
| TTM: | 80% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 28% |
| 3 Years: | 35% |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 86% |
| 3 Years: | 31% |
| 1 Year: | 52% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 0% |
| 3 Years: | 29% |
| TTM: | 77% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 0% |
| 3 Years: | 36% |
| TTM: | 100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 86% |
| 3 Years: | 31% |
| 1 Year: | 52% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|